March 29, 2017 9:28 AM ET

Pharmaceuticals

Company Overview of Xellia Pharmaceuticals AS

Company Overview

Xellia Pharmaceuticals AS manufactures pharmaceutical products. It develops, manufactures, and supplies fermented and semi-synthetic active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). The company focuses on anti-infective treatments against serious and often life-threatening infections. Its APIs and FDFs include antibacterial agents treating gram-positive and gram-negative infections, antifungal agents, corticosteroids, and biphosphonhates. The company also develops device delivery systems, such as metered dose pumps for topical formulations, ready to use injectable bag systems for use in the hospital setting, and aqueous droplet inhalation devices for out-patient use...

Silurveien 2

Oslo,  0380

Norway

Founded in 1946

Phone:

47 22 52 90 00

Fax:

47 22 52 29 49

Key Executives for Xellia Pharmaceuticals AS

Chief Executive Officer and President
Age: 53
Chief Financial Officer and Vice President
Managing Director of India
Vice President and General Counsel
Head of Production for Oslo and Operations Director of Oslo
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Algipharma AS Europe
Avexxin AS Europe
Ayanda Group AS Europe
Biolink Group AS Europe
C10 Pharma A/S Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xellia Pharmaceuticals AS, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.